Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PA-824 in Newly Diagnosed Pulmonary Tuberculosis
NCT00567840Phase 2Completed
- Sponsor
- TB Alliance
- Start
- Aug 2007
- Primary completion
- Dec 2007
- Modality
- Prodrugs/Conditional Activator Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pretomanid in pulmonary tuberculosis (TB), sponsored by TB Alliance. Started Aug 2007; status: completed.
02
Drugs
pretomanid
03
Conditions
pulmonary tuberculosis (TB)
Beyond the preview
Go deeper on NCT00567840.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00567840.